← FDA Drug Approvals (Drugs@FDA)

NEVIRAPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2017-10-06

Drug application

FDA Application #

ANDA206879

Application type

Abbreviated New Drug Application (Generic)

Brand name

NEVIRAPINE

Generic name

NEVIRAPINE

Active ingredients

NEVIRAPINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

MACLEODS PHARMS LTD

Manufacturer

Macleods Pharmaceuticals Limited

First approval

2017-10-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown